Comparing vaginal sarcoma and carcinoma in the Surveillance, Epidemiology and End Results program, 1988 to 2010: an analysis of 4,062 patients

Ghezelayagh, Talayeh

241
Comparing vaginal sarcoma and carcinoma in the Surveillance, Epidemiology and End Results program, 1988 to 2010: an analysis of 4,062 patients

Saturday, March 28, 2015: 9:55 AM

Salon C-D (Hilton Chicago)

T. Ghezelayagh^1,2, J. A. Rauh-Hain³ and W. B. Growdon³
¹UCSF School of Medicine, San Francisco, CA, ²Harvard School of Public Health, Boston, MA, ³Massachusetts General Hospital/Harvard University, Boston, MA

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

241
Comparing vaginal sarcoma and carcinoma in the Surveillance, Epidemiology and End Results program, 1988 to 2010: an analysis of 4,062 patients

241 Comparing vaginal sarcoma and carcinoma in the Surveillance, Epidemiology and End Results program, 1988 to 2010: an analysis of 4,062 patients

241
Comparing vaginal sarcoma and carcinoma in the Surveillance, Epidemiology and End Results program, 1988 to 2010: an analysis of 4,062 patients